Diasorin Spa Stock Fundamentals
| DSRLF Stock | USD 106.85 0.32 0.30% |
DiaSorin SpA fundamentals help investors to digest information that contributes to DiaSorin SpA's financial success or failures. It also enables traders to predict the movement of DiaSorin Pink Sheet. The fundamental analysis module provides a way to measure DiaSorin SpA's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to DiaSorin SpA pink sheet.
DiaSorin |
DiaSorin SpA Company Operating Margin Analysis
DiaSorin SpA's Operating Margin shows how much operating income a company makes on each dollar of sales. It is one of the profitability indicators which helps analysts to understand whether the firm is successful or not making money from everyday operations.
Current DiaSorin SpA Operating Margin | 0.29 % |
Most of DiaSorin SpA's fundamental indicators, such as Operating Margin, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, DiaSorin SpA is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
A good Operating Margin is required for a company to be able to pay for its fixed costs or payout its debt, which implies that the higher the margin, the better. This ratio is most effective in evaluating the earning potential of a company over time when comparing it against a firm's competitors.
| Competition |
Based on the recorded statements, DiaSorin SpA has an Operating Margin of 0.2942%. This is 100.84% lower than that of the Healthcare sector and 100.46% lower than that of the Diagnostics & Research industry. The operating margin for all United States stocks is 105.34% lower than that of the firm.
DiaSorin SpA Fundamental Drivers Relationships
Comparative valuation techniques use various fundamental indicators to help in determining DiaSorin SpA's current stock value. Our valuation model uses many indicators to compare DiaSorin SpA value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across DiaSorin SpA competition to find correlations between indicators driving DiaSorin SpA's intrinsic value. More Info.DiaSorin SpA is one of the top stocks in return on equity category among its peers. It also is one of the top stocks in return on asset category among its peers reporting about 0.46 of Return On Asset per Return On Equity. The ratio of Return On Equity to Return On Asset for DiaSorin SpA is roughly 2.20 . The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the DiaSorin SpA's earnings, one of the primary drivers of an investment's value.DiaSorin Operating Margin Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses DiaSorin SpA's direct or indirect competition against its Operating Margin to detect undervalued stocks with similar characteristics or determine the pink sheets which would be a good addition to a portfolio. Peer analysis of DiaSorin SpA could also be used in its relative valuation, which is a method of valuing DiaSorin SpA by comparing valuation metrics of similar companies.DiaSorin SpA is currently under evaluation in operating margin category among its peers.
DiaSorin Fundamentals
| Return On Equity | 0.2 | |||
| Return On Asset | 0.0902 | |||
| Profit Margin | 0.20 % | |||
| Operating Margin | 0.29 % | |||
| Current Valuation | 8.64 B | |||
| Shares Outstanding | 53.84 M | |||
| Shares Owned By Insiders | 57.50 % | |||
| Shares Owned By Institutions | 22.36 % | |||
| Price To Earning | 26.36 X | |||
| Price To Book | 4.73 X | |||
| Price To Sales | 5.56 X | |||
| Revenue | 1.24 B | |||
| Gross Profit | 824.77 M | |||
| EBITDA | 517.3 M | |||
| Net Income | 310.97 M | |||
| Cash And Equivalents | 382.44 M | |||
| Cash Per Share | 7.06 X | |||
| Total Debt | 1.23 B | |||
| Debt To Equity | 0.93 % | |||
| Current Ratio | 4.19 X | |||
| Book Value Per Share | 30.10 X | |||
| Cash Flow From Operations | 400.66 M | |||
| Earnings Per Share | 5.34 X | |||
| Price To Earnings To Growth | 10.57 X | |||
| Number Of Employees | 3.31 K | |||
| Beta | 0.26 | |||
| Market Capitalization | 7.15 B | |||
| Total Asset | 3.23 B | |||
| Retained Earnings | 94 M | |||
| Working Capital | 244 M | |||
| Current Asset | 361 M | |||
| Current Liabilities | 117 M | |||
| Z Score | 3.0 | |||
| Annual Yield | 0.01 % | |||
| Net Asset | 3.23 B |
About DiaSorin SpA Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze DiaSorin SpA's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of DiaSorin SpA using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of DiaSorin SpA based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.DiaSorin S.p.A. develops, manufactures, and distributes immunodiagnostics and molecular diagnostics testing kits in Europe, Africa, North America, Central and South America, the Asia Pacific, and China. The company was founded in 1968 and is headquartered in Saluggia, Italy. DIASORIN SPA operates under Diagnostics Research classification in the United States and is traded on OTC Exchange. It employs 3350 people.
Currently Active Assets on Macroaxis
Other Information on Investing in DiaSorin Pink Sheet
DiaSorin SpA financial ratios help investors to determine whether DiaSorin Pink Sheet is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in DiaSorin with respect to the benefits of owning DiaSorin SpA security.